Evidence map›Paper›PMID 27906187›Full record

ArticleCell death & disease2016

Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE

Shen Dai, Bo Wang, Wen Li, Liyang Wang, Xingguo Song, Chun Guo, Yulan Li, Fengming Liu, Faliang Zhu, Qun Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. [3-Methyladenine alleviates early renal injury in diabetic mice by inhibiting AKT signaling].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Long Non-coding Road to Atherosclerosis.Current atherosclerosis reports · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Shen DaiDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Bo WangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Wen LiDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Liyang WangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Xingguo SongDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Chun GuoDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Yulan LiDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Fengming LiuDepartment of Neuroscience, Temple University School of Medicine, Philadelphia, PA, USA.
Faliang ZhuDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Qun WangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Xiaoyan WangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Yongyu ShiDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Jianing WangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Wei ZhaoDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Lining ZhangDepartment of Immunology, Shandong University School of Medicine, Jinan 250012, Shandong, China.
Shandong University · CNTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A growing body of evidence demonstrates that autophagy, an evolutionarily conserved intracellular degradation process, is involved in the pathogenesis of atherosclerosis and has become a potential therapeutic target. Here we tested the effect of two inhibitors of phosphatidylinositol 3-kinase, 3-methyladenine (3-MA) and 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), commonly used as inhibitors of autophagy, in atherosclerosis in apolipoprotein E

Indexed as

AdenineAnimalsApolipoproteins EApoptosisAtherosclerosisAutophagyCell CountCell SurvivalCellular MicroenvironmentDiet, High-FatFoam CellsLipid DropletsLipoproteins, LDLMacrophagesMaleMice, Inbred C57BL3-methyladenineAdenineApolipoproteins ELipoproteins, LDLoxidized low density lipoprotein

Identifiers

PMID27906187
PMCPMC5260998
OpenAlexW2559578336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.